ImClone completes Erbitux BLA

IMCL and partner Bristol-Myers (BMY) said IMCL had completed its rolling BLA submission to the FDA for Erbitux (formerly IMC-C225), an anti- EGFR monoclonal antibody to treat refractory colorectal can...